Kia ora

 

Thank you for your request for official information received on 21 March
2021 for:

 

" I would like copies of all briefings, advice, aides memoire, meeting
notes or any other information regarding decisions made or to be made
relating to the funding of Trikafta in New Zealand.

I would also like to know if the company that produces Trikafta, Vertex,
has approached Pharmac to begin the process of approving Trikafta for New
Zealanders with cystic fibrosis, and, if not, whether the Minister of
Health has considered approaching Vertex to ask them to do so.
To assist in developing a response, my aim in making this request is to
ascertain the Government's current position to Trikafta to understand if
there is a timeline for the drug to become funded in New Zealand. Any
further information available that is not currently captured by the
wording of this request would be gratefully appreciated"

 

The Ministry's reference number for your request is: H202103251.

 

As required under the Official Information Act 1982, the Ministry will
endeavour to respond to your request no later than 21 April 2021, being 20
working days after the day your request was received.

 

If we are unable to respond to your request within this time frame, we
will notify you of an extension of that time frame.

 

If you have any queries related to this request, please do not hesitate to
get in touch.

 

Ngā mihi

 

OIA Services

Government Services

Office of the Director-General

Ministry of Health

E: [email address]

 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

hide quoted sections

Tēnā koe A Mark

 

Thank you for your Official Information Act request to the Ministry of
Health regarding the funding of Trikafta.

 

Under section 14 of the Act, the Ministry has decided to transfer your
request to Pharmac.  A letter outlining that decision is attached.

 

Ngā mihi

 

Antony Paltridge

Principal Advisor | OIA Services | Office of the Director-General |
Ministry of Health

 

 

 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

hide quoted sections

Kia ora A Mark

 

The Ministry of Health has transferred your request for information to
PHARMAC on 22 March 2021.

 

Your request has been received and logged. Our reference number for your
request is 2020-21-104.

 

As required under the Official Information Act 1982, we will respond to
your requests within 20 working days. You should receive a response on or
before 27 April 2021.

 

If a large amount of information has been requested, we may need to extend
the due date (this is provided for in section 15A of the Act). We will
advise you if such an extension is necessary.

 

Please feel free to contact us if you require any further assistance.

 

Ngā mihi

 

 

Melody Willis ([1]she/her) | Government Services Adviser

___________________________________________________________________

PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer
Street, Wellington

P: +64 4 460 4990 |[2]www.pharmac.govt.nz

 

------------------------------------------------------------------------

From: A Mark <[3][FOI #14970 email]>
Sent: Sunday, 21 March 2021 17:53
To: OIA Requests <[4][email address]>
Subject: Official Information request - Work done relating to Trikafta

 

Kia ora Ministry of Health,

I would like copies of all briefings, advice, aides memoire, meeting notes
or any other information regarding decisions made or to be made relating
to the funding of Trikafta in New Zealand.

I would also like to know if the company that produces Trikafta, Vertex,
has approached Pharmac to begin the process of approving Trikafta for New
Zealanders with cystic fibrosis, and, if not, whether the Minister of
Health has considered approaching Vertex to ask them to do so.

To assist in developing a response, my aim in making this request is to
ascertain the Government's current position to Trikafta to understand if
there is a timeline for the drug to become funded in New Zealand. Any
further information available that is not currently captured by the
wording of this request would be gratefully appreciated.

Yours faithfully,

A Mark

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[5][FOI #14970 email]

Is [6][Ministry of Health request email] the wrong address for Official Information
requests to Ministry of Health? If so, please contact us using this form:
[7]https://scanmail.trustwave.com/?c=15517&...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[8]https://scanmail.trustwave.com/?c=15517&...

If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.

-------------------------------------------------------------------

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

This e-mail message and any accompanying attachments may contain
confidential information. If you are not the intended recipient, please do
not read, use, disseminate, distribute or copy this message or
attachments. If you have received this message in error, please notify the
sender immediately and delete this message.

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

This e-mail message and any accompanying attachments may contain
confidential information. If you are not the intended recipient, please do
not read, use, disseminate, distribute or copy this message or
attachments. If you have received this message in error, please notify the
sender immediately and delete this message.

References

Visible links
1. https://www.publicservice.govt.nz/our-wo...
2. file:///tmp/www.pharmac.govt.nz
3. mailto:[FOI #14970 email]
4. mailto:[email address]
5. mailto:[FOI #14970 email]
6. mailto:[Ministry of Health request email]
7. https://scanmail.trustwave.com/?c=15517&...
8. https://scanmail.trustwave.com/?c=15517&...

hide quoted sections

Kia ora A Mark

 

Please find attached a response to your request for information regarding
funding decisions for Trikafta.

 

Ngā mihi

 

 

Melody Willis ([1]she/her) | Government Services Adviser

___________________________________________________________________

PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer
Street, Wellington

P: +64 4 460 4990 |[2]www.pharmac.govt.nz

This e-mail message and any accompanying attachments may contain
confidential information. If you are not the intended recipient, please do
not read, use, disseminate, distribute or copy this message or
attachments. If you have received this message in error, please notify the
sender immediately and delete this message.

References

Visible links
1. https://www.publicservice.govt.nz/our-wo...
2. file:///tmp/www.pharmac.govt.nz

hide quoted sections